Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |